Virtu Financial’s Larimar Therapeutics LRMR Stock Holding History

Virtu Financial’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Buy	+51,791	New	+$207K	0.01%	946
2025 Q4	–	Sell	-102,680	Closed	-$332K	–	1982
2025 Q3	$332K	Buy	102,680 +55,920	+120%	+$210K	0.02%	705
2025 Q2	$135K	Buy	+46,760	New	+$108K	0.01%	991
2024 Q4	–	Sell	-10,843	Closed	-$71K	–	1826
2024 Q3	$71K	Buy	+10,843	New	+$87.1K	﹤0.01%	959
2024 Q2	–	Sell	-17,578	Closed	-$133K	–	1632
2024 Q1	$133K	Buy	+17,578	New	+$137K	0.01%	875
2023 Q2	–	Sell	-32,185	Closed	-$146K	–	1806
2023 Q1	$146K	Buy	+32,185	New	+$168K	0.02%	849
2019 Q4	$117K	Buy	+8,781	New	+$83.9K	0.01%	1056
2019 Q3	–	Sell	-996	Closed	-$14K	–	1651
2019 Q2	$14K	Buy	+996	New	+$26.5K	﹤0.01%	1372
2017 Q4	–	Sell	-1,572	Closed	-$66K	–	2723
2017 Q3	$66K	Buy	+1,572	New	+$65.4K	﹤0.01%	2170

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Virtu Financial's LRMR Position: Q1 2026 in Review

Virtu Financial opened a new position in Larimar Therapeutics (LRMR) in Q1 2026: 51,791 shares worth $233K. The stake represents 0.01% of the portfolio and ranks #946 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LRMR as recently as Q3 2025.

Virtu Financial first reported a position in LRMR in Q3 2017 and has held it in 9 quarters since. The position peaked at $332K in Q3 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

Virtu Financial held 51,791 shares of Larimar Therapeutics worth $233K as of Q1 2026.
Larimar Therapeutics was a new Virtu Financial position in Q1 2026.
Larimar Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #946 holding.
Virtu Financial first reported a position in Larimar Therapeutics in Q3 2017 and has held it in 9 quarters since.
Virtu Financial's Larimar Therapeutics position peaked at $332K in Q3 2025.
162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.